{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:42:50Z","timestamp":1762004570437,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005632","name":"Forest Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.diagmicrobio.2014.01.003","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T07:47:26Z","timestamp":1389685646000},"page":"449-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010\u20132012)"],"prefix":"10.1016","volume":"78","author":[{"given":"Robert K.","family":"Flamm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helio S.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0005","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1128\/AAC.00817-12","article-title":"Activity of ceftaroline-avibactam tested against gram-negative organism populations, including strains expressing one or more beta-lactamases and methicillin-resistant Staphylococcus aureus carrying various SCCmec types","volume":"56","author":"Castanheira","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0010","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/AAC.02252-12","article-title":"Prevalence of \u03b2-lactamase encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 USA hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010)","volume":"57","author":"Castanheira","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0015","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01896-13","article-title":"Contemporary diversity of \u03b2-lactamases among Enterobacteriaceae in the nine United States census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent \u03b2-lactamase groups","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"year":"2012","author":"Clinical and Laboratory Standards Institute (CLSI)","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard: ninth edition, M07-A9","key":"10.1016\/j.diagmicrobio.2014.01.003_bb0020"},{"year":"2013","author":"Clinical and Laboratory Standards Institute (CLSI)","series-title":"Performance standards for antimicrobial susceptibility testing: 23rd informational supplement (M100-S23)","key":"10.1016\/j.diagmicrobio.2014.01.003_bb0025"},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2014.01.003_bb0030","first-page":"iii35","article-title":"Complicated skin and soft tissue infection","volume":"65","author":"Dryden","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0035","doi-asserted-by":"crossref","first-page":"11663","DOI":"10.1073\/pnas.1205073109","article-title":"Avibactam is a covalent, reversible, non-\u03b2-lactam \u03b2-lactamase inhibitor","volume":"109","author":"Ehmann","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"unstructured":"EUCAST Breakpoint tables for interpretation of MICs and zone diameters. Version 3.0, January 2013. Available at http:\/\/www.eucast.org\/clinical_breakpoints\/. Accessed January 2, 2013.","key":"10.1016\/j.diagmicrobio.2014.01.003_bb0040"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0045","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/AAC.00330-12","article-title":"Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program","volume":"56","author":"Flamm","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0050","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2147\/tcrm.2007.3.2.309","article-title":"Skin and skin structure infections: treatment with newer generation fluoroquinolones","volume":"3","author":"Giordano","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.diagmicrobio.2013.03.019","article-title":"Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds","volume":"76","author":"Goldstein","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0060","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/jac\/dks079","article-title":"Characterization of beta-lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104)","volume":"67","author":"Livermore","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.diagmicrobio.2006.05.009","article-title":"Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998\u20132004)","volume":"57","author":"Moet","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0070","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/jac\/dkq161","article-title":"Activity of chequerboard combinations of ceftaroline and NXL104 versus beta-lactamase-producing Enterobacteriaceae","volume":"65","author":"Mushtaq","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.diagmicrobio.2013.01.005","article-title":"Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010)","volume":"76","author":"Sader","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0080","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1128\/AAC.02436-12","article-title":"Antimicrobial activity of ceftaroline-avibactam tested against recent clinical isolates from USA medical centers (2010\u20132011)","volume":"57","author":"Sader","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0085","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/cid\/cir147","article-title":"Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus","volume":"52","author":"Saravolatz","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0090","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/497143","article-title":"Practice guidelines for the diagnosis and management of skin and soft-tissue infections","volume":"41","author":"Stevens","year":"2005","journal-title":"Clin Infect Dis"},{"author":"Teflaro\u00ae Package Insert","key":"10.1016\/j.diagmicrobio.2014.01.003_bb0095"},{"author":"Tygacil\u00ae Package Insert","key":"10.1016\/j.diagmicrobio.2014.01.003_bb0100"},{"key":"10.1016\/j.diagmicrobio.2014.01.003_bb0105","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1128\/AAC.00024-11","article-title":"In vivo efficacy of a human-simulated regimen of ceftaroline combined with NXL104 against ESBL- and non-ESBL-producing Enterobacteriaceae","volume":"55","author":"Wiskirchen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"author":"ZinforoTM Package Insert","key":"10.1016\/j.diagmicrobio.2014.01.003_bb0110"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889314000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889314000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:51:19Z","timestamp":1760003479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889314000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0732889314000145"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.01.003","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010\u20132012)","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}